79 related articles for article (PubMed ID: 1080867)
1. [The cellular immunological status as a prognostic factor in non-Hodgkin lymphomas].
García-Puche JL; Pérez-Alférez N; Muñóz E; Garrido F; Osorio C
Rev Clin Esp; 1975 Jul; 138(2):163-8. PubMed ID: 1080867
[No Abstract] [Full Text] [Related]
2. Cytomegalovirus-specific immune response and the cellular immune status of malignant lymphoma.
ten Napel CH; van Egten-Bijker J; Halie MR; Langenhuysen MM; The TH
J Clin Lab Immunol; 1980 Nov; 4(3):145-51. PubMed ID: 6259357
[TBL] [Abstract][Full Text] [Related]
3. [T and b lymphocytes. II. Sequential valuation in the course of leukaemia and lymphoma (author's transl)].
Pozzi DH; Jamra M; Musatti CC; Tolnai ME; Figueiredo Mendes N
Sangre (Barc); 1975; 20(3):311-22. PubMed ID: 1081741
[No Abstract] [Full Text] [Related]
4. [T and B lymphocytes. I. Assessment in leukaemia and lymphoma (author's transl)].
Jamra M; Pozzi DH; Musatti CC; Tolnai ME; Figueiredo Mendes N
Sangre (Barc); 1975; 20(3):273-87. PubMed ID: 1081740
[No Abstract] [Full Text] [Related]
5. [Serum and immunological studies in patients with lymphomas. 13. Examination of cellular immunity by specific and nonspecific stimulants].
Giraudo Conesa LC; Braun M; Pavlovsky A; Bachmann AE
Sangre (Barc); 1973; 18(3):305-12. PubMed ID: 4800716
[No Abstract] [Full Text] [Related]
6. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. II. Reticulosarcoma. (Correlation with the immunity reaction of the cellular type and the clinical status).
Libánský J; Sedlácková M; Pinosová I
Neoplasma; 1973; 20(1):61-7. PubMed ID: 4573872
[No Abstract] [Full Text] [Related]
7. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
Libánský J; Lukásová M; Pinosová I
Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205
[No Abstract] [Full Text] [Related]
8. [Stimulation of cellular immunity in patients with malignant tumors].
Govallo VI; Grigor'eva MP; Kosmiadi GA; Vostrikova NA
Vopr Onkol; 1973; 19(12):30-4. PubMed ID: 4544936
[No Abstract] [Full Text] [Related]
9. Blood B and T lymphocytes and in vitro cellular immune reactivity in untreated human malignant lymphomas and other malignant tumors.
Heier HE; Klepp R; Gundersen S; Godal T; Normann T
Scand J Haematol; 1977 Feb; 18(2):137-48. PubMed ID: 138931
[TBL] [Abstract][Full Text] [Related]
10. The immunological competence of subjects with sarcoidosis.
Mangi RJ; Dwyer JM; Gee B; Kantor FS
Clin Exp Immunol; 1974 Dec; 18(4):505-17. PubMed ID: 4283120
[TBL] [Abstract][Full Text] [Related]
11. [Normal immune function in centroblastic-centrocytic and centroblastic lymphoma].
Weisbach V; Zeiler T; Zingsem J; Heuft HG; Mempel W; Wilmanns W; Eckstein R
Beitr Infusionsther; 1990; 26():277-9. PubMed ID: 1703851
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte populations in peripheral blood in hyperthyroid and euthyroid subjects.
Lundell G; Wasserman J; Granberg PO; Blomgren H
Clin Exp Immunol; 1976 Jan; 23(1):33-9. PubMed ID: 1083317
[TBL] [Abstract][Full Text] [Related]
13. [Immunity, leukemias and lymphomas. IV. Study of immunological reactivity in malignant granuloma in relationship to the histological type].
Danieli G; Malini PL; Montroni M; Cremonini G; Lauria F
G Clin Med; 1972 May; 53(5):250-61. PubMed ID: 4655304
[No Abstract] [Full Text] [Related]
14. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
[TBL] [Abstract][Full Text] [Related]
15. [Immunological reactivity in nonlymphogranulomatous malignant lymphomas].
Loginskiĭ VE
Klin Med (Mosk); 1980 Nov; 58(11):87-92. PubMed ID: 7453122
[No Abstract] [Full Text] [Related]
16. Immunological profile in patients with non-Hodgkin's lymphomas.
Urasiński I; Fiedorowicz-Fabrycy I; Sochacka-Kuzko B; Wichert K
Arch Immunol Ther Exp (Warsz); 1983; 31(4):467-74. PubMed ID: 6689470
[TBL] [Abstract][Full Text] [Related]
17. [Immunological status of patients with solid neoplasms].
Citterio F; Luciani G; Pozzetto U; Castagneto M
Minerva Chir; 1980 May; 35(10):717-22. PubMed ID: 6969868
[No Abstract] [Full Text] [Related]
18. [Immunity, leukemias and lymphomas. 5. Effects of splenectomy on the immunological condition of patients with malignant granuloma].
Danieli G; Malini PL; Montro NI M; Cremonini G; Lauria F; Tura S
G Clin Med; 1972 Jun; 53(6):277-89. PubMed ID: 4655306
[No Abstract] [Full Text] [Related]
19. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
20. Cimetidine does not influence immunological parameters in man.
ten Berge RJ; de Pauw BE; Smeulders J; Wagener DJ
Clin Immunol Immunopathol; 1981 Oct; 21(1):33-8. PubMed ID: 6456100
[No Abstract] [Full Text] [Related]
[Next] [New Search]
